Perinatal undernutrition facilitates morphine sensitization and cross-sensitization to cocaine in adult rats: a behavioral and neurochemical study.
The development of sensitization to the locomotor effects of morphine and cross-sensitization between morphine and cocaine were evaluated in adult rats submitted to a protein malnutrition schedule from the 14th day of gestation up to 30 days of age (D-rats), and compared with well-nourished animals (C-rats). Dose-response curves to morphine-induced locomotor activity (5, 7.5, 10 or 15 mg/kg, i.p., every other day for 5 days) revealed a shift to the left in D-rats compared to C-rats. This implies that D-rats showed behavioral sensitization to the lower dose of morphine used (5 mg/kg), which was ineffective in C-rats. Furthermore, when a cocaine challenge (10 mg/kg, i.p) was given 48 h after the last morphine administration, only D-rats exhibited cross-sensitization in morphine-pretreated animals (7.5 and 10 mg/kg). In order to correlate the differential response observed with the functioning of the mesocorticolimbic dopaminergic system, extracellular dopamine (DA) levels were measured in the nucleus accumbens (core and shell) and the dorsal caudate-putamen. A challenge with cocaine in morphine pre-exposed animals produced an increase in DA release, but only in the nucleus accumbens "core" of D-rats. Similar DA levels were found in the nucleus accumbens "shell" and in the dorsal caudate-putamen of both groups. Finally, these results demonstrate that D-rats had a lower threshold for developing both a progressive behavioral sensitization to morphine and a cross-sensitization to cocaine. In accordance with these behavioral findings, a higher responsiveness of the nucleus accumbens core, expressed by increased DA levels, both basal and after cocaine challenge, was observed in D-rats.
Velazquez
E E
EE
Departamento de Farmacología, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba-IFEC (CONICET), Ciudad Universitaria, 5000 Córdoba, Argentina.
Valdomero
A
A
Orsingher
O A
OA
Cuadra
G R
GR
D000375:Aging; D000818:Animals; D002421:Caudate Nucleus / Q000187:drug effects / Q000503:physiopathology; D003042:Cocaine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D008124:Locomotion / Q000187:drug effects* / Q000502:physiology; D008297:Male; D044342:Malnutrition / Q000503:physiopathology*; D009020:Morphine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D009294:Narcotics / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D009714:Nucleus Accumbens / Q000187:drug effects / Q000503:physiopathology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011699:Putamen / Q000187:drug effects / Q000503:physiopathology; D051381:Rats; D017208:Rats, Wistar
D018765:Dopamine Uptake Inhibitors; D009294:Narcotics; D009020:Morphine; D003042:Cocaine; D004298:Dopamine